Display options
Cite
Weaver GA, Pavlinac D, Davis JS. Hepatic sensitivity to imipramine. Am J Dig Dis. 1977;22(6):551-3doi: 10.1007/BF01072511.
Weaver, G. A., Pavlinac, D., & Davis, J. S. (1977). Hepatic sensitivity to imipramine. The American journal of digestive diseases, 22(6), 551-3. https://doi.org/10.1007/BF01072511
Weaver, G A, et al. "Hepatic sensitivity to imipramine." The American journal of digestive diseases vol. 22,6 (1977): 551-3. doi: https://doi.org/10.1007/BF01072511
Weaver GA, Pavlinac D, Davis JS. Hepatic sensitivity to imipramine. Am J Dig Dis. 1977 Jun;22(6):551-3. doi: 10.1007/BF01072511. PMID: 868834.
Copy Download .nbib Format: NLM
Share it on

Am J Dig Dis. 1977 Jun;22(6):551-3. doi: 10.1007/BF01072511.

Hepatic sensitivity to imipramine.

The American journal of digestive diseases

G A Weaver, D Pavlinac, J S Davis

PMID: 868834 DOI: 10.1007/BF01072511

Abstract

A case of significant hepatic reaction related to imipramine is presented, documented by challenge with imipramine and liver biopsy. The mechanism, while not entirely clear, is presumed to involve hypersensitivity or induction of toxic metabolites.

References

  1. Can Psychiatr Assoc J. 1959;4(Suppl):152-7 - PubMed
  2. Can Psychiatr Assoc J. 1958 Oct;3(4):155-64 - PubMed
  3. Schweiz Med Wochenschr. 1957 Aug 31;87(35-36):1135-40 - PubMed
  4. JAMA. 1968 Oct 14;206(3):642-5 - PubMed
  5. Can Psychiatr Assoc J. 1959;4(Suppl):55-68 - PubMed
  6. Can Med Assoc J. 1964 Jun 13;90:1367 - PubMed
  7. Pharmacol Rev. 1965 Jun;17:101-41 - PubMed
  8. Gastroenterology. 1975 Feb;68(2):392-410 - PubMed
  9. Br Med J. 1971 Oct 9;4(5779):113 - PubMed
  10. JAMA. 1968 Nov 18;206(8):1791-2 - PubMed
  11. Clin Toxicol. 1971 Mar;4(1):47-53 - PubMed

Substances

MeSH terms

Publication Types